TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 4.47%186.66M | -25.24%338.49M | -23.67%178.66M | 10.92%452.78M | 28.38%234.06M | 47.60%408.2M | 52.03%182.32M | 19.38%276.55M | 8.54%119.92M | 25.47%231.66M |
Operating income | 4.47%186.66M | -25.24%338.49M | -23.67%178.66M | 10.92%452.78M | 28.38%234.06M | 47.60%408.2M | 52.03%182.32M | 19.38%276.55M | 8.54%119.92M | 25.47%231.66M |
Cost of sales | 0.37%-172.43M | 4.71%-365.13M | 9.17%-173.07M | -7.39%-383.16M | -25.81%-190.53M | -44.36%-356.79M | -41.48%-151.45M | -15.48%-247.15M | -9.23%-107.04M | -31.96%-214.02M |
Operating expenses | 0.37%-172.43M | 4.71%-365.13M | 9.17%-173.07M | -7.39%-383.16M | -25.81%-190.53M | -44.36%-356.79M | -41.48%-151.45M | -15.48%-247.15M | -9.23%-107.04M | -31.96%-214.02M |
Gross profit | 154.28%14.23M | -138.27%-26.65M | -87.14%5.6M | 35.43%69.62M | 41.01%43.53M | 74.86%51.41M | 139.68%30.87M | 66.69%29.4M | 3.11%12.88M | -21.45%17.64M |
Administrative expenses | 5.42%-13.15M | 21.59%-26.65M | -0.69%-13.91M | -26.81%-33.99M | -25.37%-13.81M | 1.18%-26.8M | 10.48%-11.02M | -8.27%-27.12M | -11.33%-12.31M | 8.64%-25.05M |
Impairment and provision | ---9.43M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---9.43M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | 6.29%4.06M | 258.62%9.02M | 1,857.44%3.82M | 32.14%2.52M | -86.91%195K | -10.27%1.9M | 91.76%1.49M | 35.59%2.12M | 46.88%777K | -38.56%1.57M |
Operating profit | 4.50%-4.29M | -216.04%-44.27M | -115.01%-4.49M | 43.91%38.15M | 40.14%29.91M | 502.23%26.51M | 1,479.87%21.34M | 175.31%4.4M | -31.32%1.35M | -141.83%-5.85M |
Financing cost | 27.14%-145K | 13.80%-356K | -6.42%-199K | -86.88%-413K | -281.63%-187K | -127.84%-221K | 5.77%-49K | 51.01%-97K | 51.40%-52K | -144.44%-198K |
Share of profits of associates | 14.52%10.91M | 51.57%20.06M | 41.83%9.52M | -10.31%13.23M | 17.40%6.72M | 12.12%14.76M | 114.63%5.72M | 51.02%13.16M | 151.42%2.67M | 4,310.14%8.72M |
Earning before tax | 33.91%6.47M | -148.20%-24.57M | -86.73%4.83M | 24.19%50.97M | 34.89%36.44M | 135.00%41.05M | 581.51%27.02M | 553.67%17.47M | 35.75%3.96M | 198.78%2.67M |
Tax | -85.60%271K | 120.64%1.82M | 132.14%1.88M | -114.33%-8.84M | -147.26%-5.86M | -139.43%-4.12M | -1,208.29%-2.37M | -721.66%-1.72M | -347.95%-181K | 290.14%277K |
After-tax profit from continuing operations | 0.42%6.74M | -153.97%-22.74M | -78.04%6.72M | 14.12%42.14M | 24.09%30.59M | 134.51%36.92M | 551.52%24.65M | 433.88%15.74M | 26.39%3.78M | 211.96%2.95M |
Earning after tax | 0.42%6.74M | -153.97%-22.74M | -78.04%6.72M | 14.12%42.14M | 24.09%30.59M | 134.51%36.92M | 551.52%24.65M | 433.88%15.74M | 26.39%3.78M | 211.96%2.95M |
Profit attributable to shareholders | 0.42%6.74M | -153.97%-22.74M | -78.04%6.72M | 14.12%42.14M | 24.09%30.59M | 134.51%36.92M | 551.52%24.65M | 433.88%15.74M | 26.39%3.78M | 211.96%2.95M |
Basic earnings per share | 0.62%0.0161 | -153.98%-0.0542 | -78.05%0.016 | 14.22%0.1004 | 24.19%0.0729 | 134.40%0.0879 | 552.22%0.0587 | 435.71%0.0375 | 26.76%0.009 | 211.11%0.007 |
Diluted earnings per share | 0.62%0.0161 | -153.98%-0.0542 | -78.05%0.016 | 14.22%0.1004 | 24.19%0.0729 | 134.40%0.0879 | 552.22%0.0587 | 435.71%0.0375 | 26.76%0.009 | 0.007 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers Limited | -- | PricewaterhouseCoopers Limited | -- | PricewaterhouseCoopers Limited | -- | PricewaterhouseCoopers Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.